REACHing Communities Video Series - An Interview with Perla Nunes

  Рет қаралды 431

U.S. Food and Drug Administration

U.S. Food and Drug Administration

10 күн бұрын

As part of OMHHE’s Enhance Equity Initiative, the REACHing Communities video series features interviews with members of the Racial and Ethnic Minority Acceleration Consortium for Health Equity, also known as “REACH.” In this video, Ms. Perla Nunes speaks about her ongoing work as a Project Manager and Clinical Trial Research Expert for the Federally Qualified Health Centers (FQHC) REACH Consortium.

Пікірлер
Voluntary Sodium Reduction Goals (Edition 2) Draft Guidance and Preliminary Assessment of Progress
34:22
Voluntary Sodium Reduction Goals (Edition 2) Draft Guidance and Preliminary Assessment of Progress
U.S. Food and Drug Administration
Рет қаралды 1 М.
LEADER 3D: Challenges, Strategies & Regulatory Considerations for Rare Disease Clinical Trial Design
7:39
LEADER 3D: Challenges, Strategies & Regulatory Considerations for Rare Disease Clinical Trial Design
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
小丑家的感情危机！#小丑#天使#家庭
00:15
小丑家的感情危机！#小丑#天使#家庭
家庭搞笑日记
Рет қаралды 31 МЛН
Всегда так, когда хочу что то приготовить 🥲 #aminkavitaminka #aminak #aminokka #аминкавитаминка
00:14
Всегда так, когда хочу что то приготовить 🥲 #aminkavitaminka #aminak #aminokka #аминкавитаминка
Аминка Витаминка
Рет қаралды 6 МЛН
She's very CREATIVE💡💦 #camping #survival #bushcraft #outdoors #lifehack
00:26
She's very CREATIVE💡💦 #camping #survival #bushcraft #outdoors #lifehack
Marusya Outdoors
Рет қаралды 98 МЛН
Помоги Nuggets Gegagedigedagedago удрать от бабульки Granny !
00:21
Помоги Nuggets Gegagedigedagedago удрать от бабульки Granny !
Фани Хани
Рет қаралды 2,2 МЛН
Biosimilars: Totality of the Evidence in Biosimilar Development
6:32
Biosimilars: Totality of the Evidence in Biosimilar Development
U.S. Food and Drug Administration
Рет қаралды 164
FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA - CDER Segment
1:16:43
FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA - CDER Segment
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
FDA’s Modernized Office of the Chief Scientist
3:52
FDA’s Modernized Office of the Chief Scientist
U.S. Food and Drug Administration
Рет қаралды 1,1 М.
Biosimilars: Comparative Analytical Assessment
4:39
Biosimilars: Comparative Analytical Assessment
U.S. Food and Drug Administration
Рет қаралды 117
STEM at CBER
4:26
STEM at CBER
U.S. Food and Drug Administration
Рет қаралды 255
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA - CDRH Segment
55:14
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA - CDRH Segment
U.S. Food and Drug Administration
Рет қаралды 459
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA - CBER Segment
1:05:05
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA - CBER Segment
U.S. Food and Drug Administration
Рет қаралды 592
Biosimilars: The Purple Book
5:31
Biosimilars: The Purple Book
U.S. Food and Drug Administration
Рет қаралды 115
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
57:31
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
U.S. Food and Drug Administration
Рет қаралды 407
Sickle Cell Disease: A Spotlight on Women
1:00:38
Sickle Cell Disease: A Spotlight on Women
U.S. Food and Drug Administration
Рет қаралды 877
小丑家的感情危机！#小丑#天使#家庭
00:15
小丑家的感情危机！#小丑#天使#家庭
家庭搞笑日记
Рет қаралды 31 МЛН